Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-१.२३%
१,०७८.०७
-१३.४४
-१.२३%
—१,०९१.५११,०९०.४०१,०९०.४०१,०७५.५५——
SIXC
Communications
SIXC
Communications
SIXC
-०.२४%
६०८.६७
-१.४४
-०.२४%
—६१०.११६१०.११६१०.२९६०६.१७——
SIXE
Energy
SIXE
Energy
SIXE
+०.७३%
१,२४७.००
+९.१३
+०.७३%
—१,२३७.९८१,२३७.८३१,२५२.४११,२२५.०३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९९%
१,७२७.३८
-१७.३३
-०.९९%
—१,७४४.७११,७४०.९५१,७४७.२९१,७२१.५७——
SIXM
Financials
SIXM
Financials
SIXM
-०.५०%
६३६.९७
-३.२१
-०.५०%
—६४०.१८६३९.९२६४३.१९६३६.२८——
SIXR
Staples
SIXR
Staples
SIXR
-०.६९%
८४३.७४
-५.८४
-०.६९%
—८४९.५८८४५.२७८५१.६८८४१.२८——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.५२%
२१६.३४
-१.१४
-०.५२%
—२१७.४८२१७.४८२१८.१६२१६.३३——
SIXT
Technology
SIXT
Technology
SIXT
-०.१८%
३,२५४.७७
-५.९२
-०.१८%
—३,२६०.६९३,२७३.३६३,२८७.८१३,२४०.७८——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.५०%
९३७.७०
-४.७५
-०.५०%
—९४२.४५९३९.३९९४८.८०९३४.०४——
SIXV
Health care
SIXV
Health care
SIXV
-०.४४%
१,४६०.३८
-६.४२
-०.४४%
—१,४६६.८०१,४६४.७०१,४६७.१९१,४५८.६८——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.९२%
२,३७५.३८
-२२.१२
-०.९२%
—२,३९७.५०२,३९५.०३२,४१२.०१२,३७०.६४——
PEN:NYSE
Penumbra Inc
US$ ३२४.६८
-०.२२%
(-०.७२) 1D
मे ४, १२:५४:१६ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PEN...
Open
US$ ३२४.७९
High
US$ ३२६.२०
Low
US$ ३२४.६०
Mkt. cap
१२.७७ अरब
Volume
२.७३ लाख
P/E ratio
७१.८०
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.५२
Beta
०.७४
Shares outstanding
३.९३ करोड
No. of employees
५ हजार
News stories
From sources across the web
Investing.com Nigeria
Investing.com Nigeria
·
५० मिनेट पहिले
Penumbra earnings in focus as Boston Scientific deal looms By Investing.com
The Business Journals
The Business Journals
·
३ दिन पहिले
Inside Boston Scientific's $15 billion offer for Alameda's largest employer
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend. Wikipedia
About Penumbra Inc
CEOAdam Elsesser
Employees४.७ हजार
Founded२००४
Headquarters-
Sector-
Websitepenumbrainc.com
Next call ९ दिनमा
मे १३, बुध, १६:३०
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (१.०६ est.)USD
Revenue / Estimate
-/ (३७.२० करोड est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
३२.४१ करोड
३३.९५ करोड
३५.४७ करोड
३८.५४ करोड
Cost of goods sold
१०.८३ करोड
११.५४ करोड
११.४३ करोड
१२.३३ करोड
Cost of revenue
१०.८३ करोड
११.५४ करोड
११.४३ करोड
१२.३३ करोड
Research and development expenses
२.२१ करोड
२.३२ करोड
२.२७ करोड
२.१८ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१५.३५ करोड
१६.०० करोड
१६.८९ करोड
१८.११ करोड
Operating expense
१७.५५ करोड
१८.३२ करोड
१९.१६ करोड
२०.२९ करोड
Total operating expenses
२८.३८ करोड
२९.८६ करोड
३०.५८ करोड
३२.६२ करोड
Operating income
४.०४ करोड
४.०८ करोड
४.८८ करोड
५.९२ करोड
Other non operating income
-
-
-
५.९३ लाख
EBT including unusual items
४.३९ करोड
४.५३ करोड
५.२३ करोड
६.३६ करोड
EBT excluding unusual items
४.३९ करोड
४.५३ करोड
५.२३ करोड
६.३६ करोड
Income tax expense
४६.३५ लाख
४०.०० हजार
६४.७४ लाख
१.६३ करोड
Effective tax rate
१०.५७%
०.०९%
१२.३७%
२५.६०%
Other operating expenses
-
-
-
-
Net income
३.९२ करोड
४.५३ करोड
४.५९ करोड
४.७३ करोड
Net profit margin
१२.१०%
१३.३४%
१२.९३%
१२.२८%
Earnings per share
०.८३
०.८६
०.९७
१.१८
Interest and investment income
३३.८५ लाख
३९.८९ लाख
४३.६० लाख
४५.६० लाख
Interest expense
-३.२२ लाख
-३.१९ लाख
-३.३८ लाख
-३.३३ लाख
Net interest expenses
३०.६३ लाख
३६.७० लाख
४०.२२ लाख
४२.२७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
४.५४ करोड
४.६३ करोड
५.१३ करोड
६.३५ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer